C12N 2710/24142
Virus or viral particle as vehicle
Official title: virus or viral particle as vehicle, e.g. encapsulating small organic molecule
C12N2710/24142 (Virus or viral particle as vehicle) appears on 9 US grants and 12 published applications in this corpus.
Search patents in C12N- Granted patents
- 9
- Published applications
- 12
- Assignees
- 4
- Inventors
- 21
- Latest grant
- 16 Nov 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2015 | 0 | 1 |
| 2016 | 1 | 1 |
| 2017 | 1 | 2 |
| 2018 | 1 | 0 |
| 2019 | 0 | 3 |
| 2020 | 4 | 2 |
| 2021 | 2 | 1 |
| 2022 | 0 | 2 |
By publication year.
Recent patents
- Immune modulation16 Nov 2021US 11,173,206 B2Sementis Limited
- Recombinant modified vaccinia virus ankara (MVA) respiratory syncytial virus (RSV) vaccine16 Mar 2021US 10,946,089 B2Bavarian Nordic A/S
- Integral membrane protein display on poxvirus extracellular enveloped virions22 Dec 2020US 10,870,707 B2Vaccinex, Inc.
- Integral membrane protein display on poxvirus extracellular enveloped virions3 Mar 2020US 10,577,427 B2Vaccinex, Inc.
- Integral membrane protein display on poxvirus extracellular enveloped virions4 Feb 2020US 10,550,199 B2Vaccinex, Inc.
- Recombinant vaccinia virus and pharmaceutical composition comprising same3 Nov 2022US 2022/0347244 A1Kolon Life Science, Inc.
- Immune modulation24 Mar 2022US 2022/0088189 A1Sementis Limited
- Recombinant Modified Vaccinia Virus Ankara (MVA) Respiratory Syncytial Virus (RSV) Vaccine1 Jul 2021US 2021/0196814 A1Bavarian Nordic A/S
- Integral membrane protien display on poxvirus extracellular enveloped virions9 Jul 2020US 2020/0216562 A1Vaccinex, Inc.
- Recombinant Modified Vaccinia Virus Ankara (MVA) Respiratory Syncytial Virus (RSV) Vaccine4 Jun 2020US 2020/0171142 A1Bavarian Nordic A/S
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.